Munafa Stock Market Course + Intraday & FNO calls 
Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Diamedica Therapeutics (DMAC)
Technical Analysis Report for USA stock DMAC Diamedica Therapeutics. Dated: 29 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock DMAC Diamedica Therapeutics then click here. or read Experts views on Diamedica Therapeutics or Forecast & share price targets of Diamedica Therapeutics
Diamedica Therapeutics Opened at 6.08 and Closed at: 5.99, which is -2.84% of previous session's close. It moved within a range of 5.99 and 6.44
The session was a Bearish session with an average volume of 214600, which is 59.32% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Dead cross was found 7 days back on short term averages
Support for tomorrow is 5.77 and resistance for tomorrow is 6.22
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 5.84, 5.69 resistance for tomorrow's hourly charts is 6.29, 6.59
10 Day SMA for Diamedica Therapeutics (DMAC) is 5.93 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Diamedica Therapeutics (DMAC) is 6.14 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Diamedica Therapeutics (DMAC) is 6.36 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.23 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Diamedica Therapeutics is 7.18 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Diamedica Therapeutics is at 6.14 and 200 DMA is at 7.18, while 50 DMA and 100 DMA are at 6.36 and 7.23 respectively
Diamedica Therapeutics (DMAC) moving average of 20 SMA is at 6.14 and 20 EMA is at 6.12
| Date | Closing Price | 20 SMA | 20 EMA |
| 29 Fri May | 5.99 | 6.14 | 6.12 |
| 28 Thu May | 6.16 | 6.15 | 6.13 |
| 27 Wed May | 6.10 | 6.15 | 6.13 |
| 26 Tue May | 6.32 | 6.14 | 6.13 |
| 22 Fri May | 5.91 | 6.14 | 6.11 |
| 21 Thu May | 5.77 | 6.16 | 6.13 |
Diamedica Therapeutics (DMAC) moving average of 50 SMA is at 6.36 and 50 EMA is at 6.46
| Date | Closing Price | 50 SMA | 50 EMA |
| 29 Fri May | 5.99 | 6.36 | 6.46 |
| 28 Thu May | 6.16 | 6.38 | 6.48 |
| 27 Wed May | 6.10 | 6.4 | 6.49 |
| 26 Tue May | 6.32 | 6.42 | 6.51 |
| 22 Fri May | 5.91 | 6.44 | 6.52 |
| 21 Thu May | 5.77 | 6.46 | 6.55 |
Diamedica Therapeutics (DMAC) moving average of 100 SMA is at 7.23 and 100 EMA is at 6.8
| Date | Closing Price | 100 SMA | 100 EMA |
| 29 Fri May | 5.99 | 7.23 | 6.8 |
| 28 Thu May | 6.16 | 7.26 | 6.82 |
| 27 Wed May | 6.10 | 7.28 | 6.83 |
| 26 Tue May | 6.32 | 7.29 | 6.84 |
| 22 Fri May | 5.91 | 7.31 | 6.85 |
| 21 Thu May | 5.77 | 7.34 | 6.87 |
Diamedica Therapeutics (DMAC) moving average of 200 SMA is at 7.18 and 200 EMA is at 6.77
| Date | Closing Price | 200 SMA | 200 EMA |
| 29 Fri May | 5.99 | 7.18 | 6.77 |
| 28 Thu May | 6.16 | 7.18 | 6.78 |
| 27 Wed May | 6.10 | 7.18 | 6.79 |
| 26 Tue May | 6.32 | 7.17 | 6.8 |
| 22 Fri May | 5.91 | 7.16 | 6.8 |
| 21 Thu May | 5.77 | 7.15 | 6.81 |
Baxter International has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Baxter International, about 13.99% more returns!
Diamedica Therapeutics has performed better than Redhill Biopharma in short term. Holding Diamedica Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Rocket Pharmaceuticals in short term. Holding Diamedica Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Pacira Pharmaceuticals in short term. Holding Diamedica Therapeutics could be a better choice for now!
Diamedica Therapeutics has performed better than Orthofix Medical in short term. Holding Diamedica Therapeutics could be a better choice for now!
Moleculin Biotech has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 13.09% more returns!
Diamedica Therapeutics has performed better than Irhythm Technologies in short term. Holding Diamedica Therapeutics could be a better choice for now!
Fate Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Fate Therapeutics, about 58.77% more returns!
Evolus Inc has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Evolus Inc, about 18.34% more returns!
Entera Bio has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Entera Bio, about 23.51% more returns!
Diamedica Therapeutics has performed better than Ensign Group in short term. Holding Diamedica Therapeutics could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 8.9% more returns!
Catalyst Biosciences has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 16.22% more returns!
Biogen Inc has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Biogen Inc, about 5.69% more returns!
Diamedica Therapeutics has performed better than Biocryst Pharmaceuticals in short term. Holding Diamedica Therapeutics could be a better choice for now!
Autolus Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 19.34% more returns!
Assembly Biosciences has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 0.41% more returns!
Aldeyra Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 8.35% more returns!
Diamedica Therapeutics Technical analysis of indicators
Price action analysis of Diamedica Therapeutics (DMAC) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Diamedica Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.91 and Diamedica Therapeutics DMAC stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics DMAC stock. Volume based technical analysis of Diamedica Therapeutics DMAC stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock DMAC Diamedica Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And DMAC Experts View which covers a lot of information including buying and selling signals
DMAC future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Diamedica Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
